This case highlights not only the challenges of diagnosing and managing PTH-mediated hypercalcemia but also demonstrates the therapeutic benefits and risks associated with bisphosphonate treatment in complex cases involving advanced age and CKD. This evidence concerns the gene PTH and chronic kidney disease.